NCOR2

NCOR2 Full Name

nuclear receptor corepressor 2

NCOR2 Introduction

NCOR2 (nuclear receptor corepressor 2), best known by its alternative name SMRT (silencing mediator of retinoic acid and thyroid hormone receptors), is a large corepressor protein that enables nuclear hormone receptors and many other transcription factors to silence gene expression. Whereas nuclear receptors such as the thyroid hormone and retinoic acid receptors activate transcription when bound by their ligands, in the unliganded state they recruit corepressors; SMRT and its close relative N-CoR provide the platform that connects these receptors to histone-modifying enzymes, particularly histone deacetylase 3 (HDAC3), which compacts chromatin and represses transcription. Beyond nuclear receptors, SMRT is recruited by a remarkable diversity of transcription factors involved in development, metabolism, circadian rhythms, and immune function, giving the corepressor broad influence over cell fate decisions. The importance of NCOR2 is underscored by its involvement in human disease: chromosomal translocations that fuse SMRT with other proteins occur in some leukemias, and altered SMRT expression or function has been linked to metabolic disorders, muscle wasting, and cancer. Because the corepressor must be actively removed or inactivated for target genes to be turned on, the dynamic regulation of NCOR2 is a key control point in gene regulation, and pharmacological modulation of its interactions is an active area of therapeutic research.

Figure 1. The structure of NCOR2.

Corepressor Domain Architecture and Complex Assembly
The NCOR2/SMRT protein is very large, and its functional organization reflects its role as a molecular scaffold for transcriptional repression.
It contains multiple interaction surfaces, including domains that bind nuclear receptors and a conserved corepressor motif through which it recruits the enzyme HDAC3 together with additional subunits.
The canonical repression complex assembled by SMRT includes HDAC3, the transducin beta-like proteins TBL1 and TBLR1, and the G-protein pathway suppressor GPS2, all of which cooperate to deacetylate histones and silence nearby genes.
Recruitment of SMRT to a target gene can occur through direct contact with an unliganded nuclear receptor or through association with sequence-specific repressors such as the BCL6 oncoprotein and several homeodomain factors.
The NCOR2 gene is located on human chromosome 12, and alternative splicing gives rise to multiple SMRT isoforms whose tissue distribution and interaction preferences differ.
The activity of the corepressor is controlled by signaling pathways that induce its phosphorylation, sumoylation, or nuclear export, allowing extracellular signals to relieve repression rapidly without degrading the protein.
This dynamic regulation enables a single corepressor to mediate both stable developmental silencing and reversible, signal-responsive gene control.

Development, Metabolism, Leukemia, and Therapeutic Opportunities
During development SMRT is essential for the correct specification of many cell types, and its loss in model organisms causes profound defects in organogenesis, including abnormalities of the heart, muscle, and nervous system.
In the endocrine system, SMRT modulates the sensitivity of tissues to thyroid hormone, retinoic acid, and steroid hormones, and dysregulation of corepressor activity contributes to hormone-resistance states.
SMRT also restrains the activity of BCL6, a transcriptional repressor that is frequently overexpressed in diffuse large B-cell lymphoma, and disruption of the SMRT-BCL6 interaction is being explored as a therapeutic strategy in this disease.
Chromosomal translocations that create SMRT fusion proteins have been identified in subsets of acute leukemia, where the aberrant fusion converts a transcriptional corepressor into a driver of leukemic gene expression.
In metabolism, SMRT regulates the expression of genes controlling glucose and lipid handling, adipogenesis, and circadian metabolism, linking corepressor function to obesity and insulin resistance.
Small molecules that mimic the receptor-corepressor interaction and stabilize repression, or conversely that disrupt SMRT complexes in cancer cells, represent promising avenues for modulating gene expression programs therapeutically.

Alternate Names for NCOR2

NCOR2; nuclear receptor corepressor 2; SMRT; TRAC; CTG26; SMRTE; TRAC1; N-CoR2; TNRC14; TRAC-1; SMAP270; SMRTE-tau; CTG repeat protein 26; T3 receptor-associating factor; thyroid-, retinoic-acid-receptor-associated corepressor; silencing mediator for retinoid and thyroid hormone receptors;

View more